Gamma camera in Nuclear Medicine is used for –
Investigation of choice for leptomeningeal carcinomatosis:
Which radioisotope is PRIMARILY used for detecting acute myocardial infarction rather than assessing myocardial perfusion?
A patient is suspected to have vestibular schwannoma. The investigation of choice for its diagnosis is:
In a child, non-functioning kidney is best diagnosed by:
Tc-labeled RBCs are used for all except:
Which of the following liver metastases appear hypoechoic on ultrasound?
A 48-year-old woman presents with suspected myocardial ischemia. Pharmacologic stress myocardial perfusion SPECT with Tc-99m sestamibi shows reversible perfusion defect in the inferior wall. Evaluate the optimal management approach based on this functional imaging finding.
A 70-year-old male with recurrent prostate cancer post-prostatectomy has rising PSA (4.2 ng/mL) but negative conventional imaging. Which functional imaging modality would provide the highest detection rate for disease localization in this clinical scenario?
A 58-year-old presents with progressive cognitive decline. MRI brain is unremarkable. FDG-PET shows bilateral temporoparietal and posterior cingulate hypometabolism with relative sparing of sensorimotor cortex. Analyze these findings to determine the most likely diagnosis.
Explanation: ***Organ imaging*** - A **gamma camera** is primarily used to detect gamma rays emitted from **radiopharmaceuticals** introduced into the body. - This detection allows for the creation of 2D images or 3D tomographic images (SPECT) of organ function and structure. *Measuring the radioactivity* - While radioactivity is measured by the gamma camera, its primary purpose is not just to quantify dps/Bq, but to create a **spatial distribution** of this radioactivity. - Dedicated **dosimeters** or **activity meters** are used for precise measurement of radioactivity. *RIA* - **Radioimmunoassay (RIA)** is a laboratory technique used to measure the concentration of substances (e.g., hormones, drugs) in a sample, not a function of the gamma camera. - RIA utilizes **radioactively labeled antibodies** and antigens but does not involve imaging the body. *Monitoring the surface contamination* - **Geiger counters** or specific contamination meters are used for monitoring surface contamination. - A gamma camera is designed for internal imaging and is not practical or optimized for detecting external surface contamination.
Explanation: ***Gd enhanced MRI*** - **Gadolinium-enhanced MRI** is the investigation of choice for **leptomeningeal carcinomatosis** as it can visualize the subtle nodular or linear enhancement along the leptomeninges, indicating tumor dissemination. - It offers superior **soft tissue contrast** and spatial resolution compared to CT, enabling detection of small lesions and accurate mapping of disease extent. *CT scan* - A **CT scan** has limited sensitivity for detecting leptomeningeal involvement due to poor contrast resolution of soft tissues and the dura/arachnoid spaces. - It might show hydrocephalus or large tumor deposits, but subtle leptomeningeal enhancement is often missed. *SPECT* - **Single photon emission computed tomography (SPECT)** is primarily used for functional imaging and is not the investigation of choice for anatomical visualization of leptomeningeal carcinomatosis. - Its resolution is too low to detect the fine structural changes associated with leptomeningeal spread. *PET* - **Positron emission tomography (PET)**, often combined with CT, identifies metabolically active tumor cells and can detect diffuse metastatic disease. - While useful for overall cancer staging and identifying primary lesions, it is less effective than gadolinium-enhanced MRI for directly visualizing the morphology and enhancement patterns of leptomeningeal carcinomatosis due to limited spatial resolution in the CSF spaces.
Explanation: ***Tc-99m Pyrophosphate*** - This radioisotope binds to **calcium deposits** in infarcted myocardial tissue, which accumulate 12-24 hours after injury. - It is particularly useful for detecting **acute myocardial infarction** (hot spot imaging) when cardiac biomarkers may be unreliable or in cases of delayed presentation. - Shows positive uptake in necrotic tissue, making it a "positive" or "hot spot" agent for acute MI. *Thallium 201* - **Thallium 201** is a potassium analog that is actively transported into viable myocardial cells. - It is primarily used for assessing **myocardial perfusion** and viability, showing areas of reduced blood flow or scar tissue. - Acts as a "cold spot" agent - infarcted areas show reduced uptake. *Tc-99m Sestamibi* - **Tc-99m Sestamibi** is a commonly used tracer for **myocardial perfusion imaging (SPECT)**, indicating blood flow to the heart muscle. - It accumulates in viable myocardial cells in proportion to blood flow and is not specific for acute myocardial necrosis. - Used primarily for stress testing and perfusion assessment, not acute infarct detection. *18-FDG PET* - **18-FDG PET** (Fluorodeoxyglucose Positron Emission Tomography) primarily measures **glucose metabolism** in the myocardium. - It is predominantly used to assess **myocardial viability** in areas of hibernating myocardium rather than acute infarction. - Helps distinguish viable but ischemic tissue from scar tissue.
Explanation: ***Gadolinium enhanced MRI*** - **Gadolinium-enhanced MRI** is the **gold standard** for diagnosing vestibular schwannomas due to its superior soft tissue contrast and ability to visualize the fine structures of the **cerebellopontine angle** and internal auditory canal. - Vestibular schwannomas enhance brightly with gadolinium, allowing for clear delineation of the tumor from surrounding brain tissue and nerves, even when small. *SPECT* - **SPECT** (Single-Photon Emission Computed Tomography) is primarily used for assessing **brain perfusion**, **metabolism**, or receptor activity, not for detailed anatomical imaging of tumors like schwannomas. - It has **limited spatial resolution** compared to MRI and would not accurately visualize a vestibular schwannoma, especially when small. *PET scan* - **PET scans** (Positron Emission Tomography) are mainly used to detect **metabolically active tumors** or differentiate benign from malignant lesions, as well as for staging cancer and assessing treatment response. - While it can detect some tumors, PET is **not the primary imaging modality** for initial diagnosis of vestibular schwannoma, as MRI provides superior anatomical detail. *Contrast enhanced CT scan* - A **contrast-enhanced CT scan** can identify larger vestibular schwannomas, especially if they cause **bone erosion** of the internal auditory canal. - However, CT has **inferior soft tissue resolution** compared to MRI, making it less sensitive for detecting small tumors or differentiating them from adjacent structures in the posterior fossa.
Explanation: ***DTPA renogram*** - A **DTPA (diethylenetriamine pentaacetic acid) renogram** is a nuclear medicine study that assesses **renal blood flow**, **glomerular filtration**, and urinary drainage. It directly measures the function of each kidney by quantifying tracer uptake and excretion, making it ideal for diagnosing a non-functioning kidney in a child. - The test provides information on the **relative function** of each kidney and outflow obstruction, which is crucial for determining if a kidney is truly non-functioning rather than just poorly visualized. *Ultrasonography* - While ultrasound can visualize the **anatomy** of the kidney (size, shape, presence of hydronephrosis), it does not directly assess renal function. - It may show a small, atrophic, or poorly developed kidney, but cannot definitively determine if it is non-functioning without functional studies. *IVU (Intravenous Urogram)* - An **IVU** relies on the kidneys' ability to excrete contrast material, which is visualized by X-ray. If a kidney is non-functioning, it will not excrete the contrast, leading to non-visualization. - However, IVU exposes the child to **radiation** and **iodinated contrast**, and newer, safer, and more precise functional studies like renograms are preferred, especially in pediatric cases where radiation exposure should be minimized. *Creatinine clearance* - **Creatinine clearance** is a measure of overall **glomerular filtration rate (GFR)** for both kidneys combined. - It does not provide information on the individual function of each kidney, so it cannot diagnose a non-functioning unilateral kidney.
Explanation: ***Liver adenoma*** - Tc-labeled RBCs are primarily used to highlight a specific type of tissue or process. **Liver adenomas** do not typically show an affinity for **Tc-labeled RBCs**, as they are benign epithelial tumors with a different vascular composition. - While adenomas can be vascular, they do not inherently contain the **vascular pooling** or blood volume characteristics that would be specifically targeted by **Tc-labeled RBCs** for diagnostic imaging. *LV function* - **Tc-labeled RBCs** (or Tc-99m-pertechnetate) are commonly used in **gated blood pool imaging** (MUGA scan) to assess **left ventricular (LV) function**, including **ejection fraction** and wall motion abnormalities. - This technique directly visualizes the blood pool within the cardiac chambers, making it suitable for assessing functional parameters of the heart. *GI bleeding* - **Tc-labeled RBCs** are a standard imaging agent for detecting and localizing **active gastrointestinal (GI) bleeding**, especially when the bleeding rate is intermittent or slow. - The labeled RBCs extravasate at the site of hemorrhage, creating a 'hot spot' that can be identified over time. *Liver hemangioma* - **Tc-labeled RBCs** are highly effective in diagnosing **liver hemangiomas**, which are benign vascular tumors composed of large, dilated blood vessels. - These lesions show characteristic uptake and retention of **labeled RBCs** due to their slow blood flow and large intravascular space, appearing as early peripheral enhancement with subsequent centripetal filling.
Explanation: **Breast cancer** - Liver metastases from **breast cancer** frequently present as **hypoechoic lesions** on ultrasound, due to the tumor's cellular composition and vascularity. - This appearance helps differentiate them from other more commonly echogenic or mixed metastatic patterns. *RCC* - **Renal cell carcinoma (RCC)** metastases to the liver often appear **hyperechoic** or **mixed echogenicity** on ultrasound due to their rich vascularity. - This is a distinct characteristic, different from the predominantly hypoechoic nature seen with breast cancer metastases. *Colon cancer* - Liver metastases from **colon cancer** are typically **echogenic** or **mixed echogenicity** on ultrasound, sometimes with a hypoechoic rim ("target sign"). - Their presentation is generally not purely hypoechoic, making them distinguishable from breast cancer metastases. *Mucinous adenocarcinoma* - Liver metastases from **mucinous adenocarcinoma** can be quite variable, but they often appear **complex**, possibly with **cystic components** or mixed echogenicity, rather than uniformly hypoechoic. - The mucin content can create a distinct internal architecture on ultrasound that differs from solid hypoechoic lesions.
Explanation: ***Recommend coronary angiography for further evaluation and potential revascularization*** - A **reversible perfusion defect** on SPECT denotes **stress-induced ischemia** with viable myocardium, characterized by reduced tracer uptake during stress that normalizes at rest. - This finding indicates significant **coronary artery stenosis** (often >70%) and requires **coronary angiography** to define the anatomy and plan possible **percutaneous coronary intervention (PCI)**. *Reassure patient as findings represent artifact* - While **diaphragmatic attenuation** can cause inferior wall artifacts, a truly **reversible defect** (normal rest scan) is diagnostic of ischemia rather than a permanent artifact. - Attenuation artifacts typically present as **fixed defects** or are clarified using **ECG-gated SPECT** to check for normal wall motion. *Start medical management without further investigation* - Although medical therapy is a pillar of CAD treatment, a documented **reversible defect** in a symptomatic patient warrants anatomical assessment to evaluate the risk of **major adverse cardiovascular events (MACE)**. - Management solely with drugs is insufficient for patients with high-risk ischemia patterns on **functional imaging** who may benefit from revascularization. *Proceed directly to coronary artery bypass grafting* - **Coronary artery bypass grafting (CABG)** is a surgical intervention that requires prior visualization of coronary anatomy via angiography to determine the extent of disease (e.g., **triple-vessel** or **left main disease**). - It is premature to provide surgical referral before confirming the **syntax score** or the suitability of the lesions for less invasive procedures like **angioplasty**.
Explanation: ***68Ga-PSMA PET-CT*** - **68Ga-PSMA PET-CT** is currently the gold standard for detecting **biochemical recurrence** of prostate cancer, showing a detection rate of over 90% when PSA levels are >2 ng/mL. - It targets the **Prostate-Specific Membrane Antigen**, which is significantly overexpressed in prostate cancer cells, allowing for precise localization of both local recurrence and **distant metastases**. *In-111 Capromab pendetide scan* - This older imaging modality (ProstaScint) targets an **intracellular epitope** of PSMA, which is less accessible in viable, non-necrotic cells compared to the extracellular targets of modern tracers. - It has a much lower **sensitivity and specificity** compared to 68Ga-PSMA PET-CT and is rarely used in contemporary clinical practice. *18F-FDG PET-CT* - **18F-FDG** is generally not useful for prostate cancer because these tumors are typically slow-growing and have **low glucose metabolism** (low glycolytic rate). - It is primarily reserved for **aggressive, high-grade**, or neuroendocrine-differentiated prostate cancers that have lost the ability to express PSMA. *Tc-99m MDP bone scan* - This is a conventional imaging modality that detects **osteoblastic activity** rather than the cancer cells themselves, often resulting in low sensitivity at low PSA levels. - It is specifically limited to detecting **bone metastases** and cannot identify soft tissue recurrence or lymph node involvement in the pelvis.
Explanation: ***Alzheimer's disease*** - The classic FDG-PET findings for this condition involve bilateral **temporoparietal** and **posterior cingulate** hypometabolism while typically sparing the **sensorimotor cortex**. - This metabolic signature often appears during the **prodromal phase**, frequently preceding the structural **atrophy** seen on traditional MRI scans. *Normal pressure hydrocephalus* - On imaging, this condition is characterized by **ventriculomegaly** disproportionate to the degree of cortical atrophy, which is not described here. - Clinically, it presents with the classic triad of **gait disturbance**, **urinary incontinence**, and **dementia**, rather than isolated metabolic patterns on PET. *Frontotemporal dementia* - FDG-PET would typically demonstrate hypometabolism localized to the **frontal** and **anterior temporal lobes**, which differs from the posterior pattern seen in this case. - Early symptoms usually include significant **personality changes** or **behavioral disturbances** rather than generalized progressive cognitive decline alone. *Vascular dementia* - PET scanning usually shows a **focal or multifocal** "patchy" pattern of hypometabolism corresponding to areas of prior **infarction** or chronic ischemia. - Diagnosis is generally supported by MRI evidence of **lacunar infarcts**, **extensive white matter disease**, or territorial strokes.
Get full access to all questions, explanations, and performance tracking.
Start For Free